Senior Leadership

高层领导

• 批准号: 8533978
• 负责人: Andrew S Kraft
• 金额: $ 6.58万
• 依托单位: MEDICAL UNIVERSITY OF SOUTH CAROLINA
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-04-01 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/8533978
• 关键词: Address; Area; Basic Science; Behavioral Sciences; Bioinformatics; Biometry; Cancer Center; Cancer Center Support Grant; Cancer Control; Cancer Control Research; Charge; Clinical; Clinical Trials; Collaborations; Community Outreach; Consensus; Counseling; Development; Discipline; Doctor of Philosophy; Elements; Ensure; Epidemiology; Evaluation; Faculty; Funding; Gap Junctions; Goals; Individual; Institution; Lead; Leadership; Medical; Molecular Epidemiology; Physician Executives; Population Sciences; Positioning Attribute; Public Health; Recommendation; Research; Research Personnel; Resource Allocation; Resource Development; Resource Sharing; Resources; South Carolina; Strategic Planning; Techniques; Time; Translational Research; Universities; Vision; Work; authority; base; behavioral/social science; cancer health disparity; cancer prevention; experience; meetings; member; outreach; programs; research and development

The Rollings Cancer Center (HCC) is directed by Andrew S. Kraft, MD (Director) with the assistance of Anthony J. Alberg, PhD, MPH (Associate Director of Cancer Prevention & Control); Daniel J. Fernandes, PhD (Associate Director of Translational Research); Marvella E. Ford, PhD (Associate Director of Cancer Disparities); Yusuf A. Hannun, MD (Associate Director of Basic Sciences); Anita L. Harrison, MPA (Associate Director of Administration); Carolyn E. Reed, MD (Associate Director of Medical Affairs); Steven A. Rosenzweig, PhD (Assistant Director of Shared Resources); and Melanie B. Thomas, MD (Associate Director of Clinical Investigations). These experienced individuals are organized as a Senior Leadership team that represents the strong functional nexus of this matrix-based Center. Dr. Kraft has charged the members of the team with employing consensus building techniques as they work directly with the various HCC boards/councils and committees to formulate priorities, strategies and allocation of resources. The Senior Leadership team works together to ensure consistency in the vision and goals of the Center; develop synergistic interactions among the basic, translational, and clinical elements of the Center; plan proactive approaches to the development of the research base and resources; effectively leverage all available resources at MUSC and at the state and national levels; engage in community outreach; and oversee all activities of the HCC. The Senior Leadership team meets several times a month in the context of HCC's various board/committee/council meetings, one-on-one with the Director, and once a month as a formal Executive Council. They provide direct counsel and recommendations to the Director based on these interactions. All final authority for decisions on behalf of the HCC resides with the Director.

罗林斯癌症中心（HCC）由Andrew S. Kraft，MD（董事）， Anthony J. Alberg，PhD，MPH（癌症预防和控制副主任）;丹尼尔J.费尔南德斯， PhD（Associate Director of Translational Research）; Marvella E.福特博士（癌症副主任 Disparities）; Yusuf A. Hannun，MD（基础科学副主任）; Anita L. Harrison，MPA（Associate 行政总监）; Reed，MD（医学事务副总监）; Steven A. Rosenzweig博士（共享资源助理总监）和Melanie B。托马斯，医学博士（助理 临床研究总监）。这些经验丰富的个人被组织为高级领导 这个团队代表了这个矩阵式中心强大的功能联系。克拉夫特医生指控 团队成员在直接与各种 总部合同委员会各理事会和委员会制定优先事项、战略和资源分配。的 高级领导团队共同努力，确保中心愿景和目标的一致性; 中心的基础、翻译和临床要素之间的协同互动;主动计划 发展研究基础和资源的方法;有效地利用所有可用的 资源在MUSC和州和国家一级;参与社区外展;并监督所有 HCC的活动。 高级领导小组每月在总部合同委员会的各种活动范围内举行几次会议， 董事会/委员会/理事会会议，与董事一对一，每月一次作为正式执行官 理事会。他们根据这些互动向主任提供直接咨询意见和建议。所有 代表合同委员会作出决定的最终权力属于主任。